Literature DB >> 11689079

Antitumor Agents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents.

Y Xia1, Z Y Yang, P Xia, T Hackl, E Hamel, A Mauger, J H Wu, K H Lee.   

Abstract

Fluorinated 2-phenyl-4-quinolone derivatives were synthesized and evaluated in National Cancer Institute's 60 human tumor cell line in vitro screen. From the results, the ketone moiety plays an essential role in activity. Among the compounds tested, 2'-fluoro-6-pyrrol-2-phenyl-4-quinolone (13) exhibited the most potent cytotoxic activities (log GI(50) < -8.00) against renal and melanoma tumor cell lines. Compound 13 was also a potent inhibitor of tubulin polymerization (IC(50) = 0.46 microM) and of radiolabeled colchicine binding to tubulin, with activities comparable to those of the potent antimitotic natural products colchicine, podophyllotoxin, and combretastatin A-4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689079     DOI: 10.1021/jm0101085

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

Review 2.  Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.

Authors:  Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

Review 3.  Epigenetic polypharmacology: A new frontier for epi-drug discovery.

Authors:  Daniela Tomaselli; Alessia Lucidi; Dante Rotili; Antonello Mai
Journal:  Med Res Rev       Date:  2019-06-20       Impact factor: 12.944

4.  CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulation.

Authors:  An-Chi Tsai; Shiow-Lin Pan; Hui-Lung Sun; Chih-Ya Wang; Chieh-Yu Peng; Shih-Wei Wang; Ya-Ling Chang; Sheng-Chu Kuo; Kuo-Hsiung Lee; Che-Ming Teng
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

5.  Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors.

Authors:  Newaj M Abdullah; Gus R Rosania; Kerby Shedden
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

6.  Design and synthesis of 2-(3-benzo[b]thienyl)-6,7-methylenedioxyquinolin-4-one analogues as potent antitumor agents that inhibit tubulin assembly.

Authors:  Yu-Hsun Chang; Mei-Hua Hsu; Sheng-Hung Wang; Li-Jiau Huang; Keduo Qian; Susan L Morris-Natschke; Ernest Hamel; Sheng-Chu Kuo; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

7.  Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity.

Authors:  Mostafa M Elbadawi; Wagdy M Eldehna; Wenjie Wang; Keli K Agama; Yves Pommier; Manabu Abe
Journal:  Eur J Med Chem       Date:  2021-02-09       Impact factor: 7.088

8.  Study of the cytotoxic/toxic potential of the novel anticancer selenodiazoloquinolone on fibroblast cells and 3D skin model.

Authors:  Soňa Jantová; Dominika Topoľská; Michaela Janošková; Miroslav Pánik; Viktor Milata
Journal:  Interdiscip Toxicol       Date:  2017-05-17

9.  Direct one-pot synthesis of primary 4-amino-2,3-diaryl-quinolines via Suzuki-Miyaura cross-coupling of 2-aryl-4-azido-3-iodoquinolines with arylboronic acids.

Authors:  Malose Jack Mphahlele; Mamasegare Mabel Mphahlele
Journal:  Molecules       Date:  2011-10-25       Impact factor: 4.411

Review 10.  Recent advances in the synthesis of N-containing heteroaromatics via heterogeneously transition metal catalysed cross-coupling reactions.

Authors:  Laurent Djakovitch; Nelly Batail; Marie Genelot
Journal:  Molecules       Date:  2011-06-23       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.